相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Passive immunity in the prevention of rabies
Leonard Both et al.
LANCET INFECTIOUS DISEASES (2012)
Llama-Derived Single Domain Antibodies to Build Multivalent, Superpotent and Broadened Neutralizing Anti-Viral Molecules
Anna Hultberg et al.
PLOS ONE (2011)
Failure of Rabies Postexposure Prophylaxis In Patients Presenting with Unusual Manifestations
Prapimporn Shantavasinkul et al.
CLINICAL INFECTIOUS DISEASES (2010)
Rabies and African bat lyssavirus encephalitis and its prevention
Mary Warrell
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Quantifying Antigenic Relationships among the Lyssaviruses
D. L. Horton et al.
JOURNAL OF VIROLOGY (2010)
Plant-specific glycosylation patterns in the context of therapeutic protein production
Veronique Gomord et al.
PLANT BIOTECHNOLOGY JOURNAL (2010)
pEAQ: versatile expression vectors for easy and quick transient expression of heterologous proteins in plants
Frank Sainsbury et al.
PLANT BIOTECHNOLOGY JOURNAL (2009)
The fight against rabies in Africa: From recognition to action
Betty Dodet
VACCINE (2009)
Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals
Charles E. Rupprecht et al.
VACCINE (2009)
Furious Rabies after an Atypical Exposure
Heiman F. L. Wertheim et al.
PLOS MEDICINE (2009)
Development of a Mouse Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis in Humans
Thomas Mueller et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison
Edward Wright et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma:: Safety and immunogenicity in a phase I clinical study
A. A. McCormick et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides
Johannes Stadlmann et al.
PROTEOMICS (2008)
First administration to humans of a monoclonal antibody cocktail against rabies virus: Safety, tolerability, and neutralizing activity
A. B. H. Bakker et al.
VACCINE (2008)
Rabies Exposures, Post-Exposure Prophylaxis and Deaths in a Region of Endemic Canine Rabies
Katie Hampson et al.
PLOS NEGLECTED TROPICAL DISEASES (2008)
Use of neutralizing murine monoclonal antibodies to rabies glycoprotein in passive immunotherapy against rabies
Kader Muhamuda et al.
HUMAN VACCINES (2007)
Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates
Susan E. Sloan et al.
VACCINE (2007)
Rabies encephalitis in malaria-endemic area, Malawi, Africa
Macpherson Mallewa et al.
EMERGING INFECTIOUS DISEASES (2007)
Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin
J Goudsmit et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants
ABH Bakker et al.
JOURNAL OF VIROLOGY (2005)
Efficacy of rabies biologics against new lyssaviruses from Eurasia
CA Hanlon et al.
VIRUS RESEARCH (2005)
Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: Fine mapping and escape mutant analysis
WE Marissen et al.
JOURNAL OF VIROLOGY (2005)
Antibody processing and engineering in plants, and new strategies for vaccine production
JKC Ma et al.
VACCINE (2005)
Prophylaxis against rabies
CE Rupprecht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Controlled glycosylation of therapeutic antibodies in plants
Y Tekoah et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2004)
Identification of a conserved linear epitope at the N terminus of the rabies virus glycoprotein
KL Mansfield et al.
JOURNAL OF GENERAL VIROLOGY (2004)
Novel lyssaviruses isolated from bats in Russia
AD Botvinkin et al.
EMERGING INFECTIOUS DISEASES (2003)
Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies
M Prosniak et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Function and glycosylation of plant-derived antiviral monoclonal antibody
KS Ko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Immunoreactivity in mammals of two typical plant glyco-epitopes, core α(1,3)-fucose and core xylose
M Bardor et al.
GLYCOBIOLOGY (2003)
New lyssavirus genotype from the Lesser Mouse-eared bat (Myotis blythi), Kyrghyzstan
YT Arai et al.
EMERGING INFECTIOUS DISEASES (2003)
The challenge to provide affordable rabies post-exposure treatment
MJ Warrell
VACCINE (2003)
Bat lyssaviruses (Aravan and Khujand) from Central Asia: phylogenetic relationships according to N, P and G gene sequences
IV Kuzmin et al.
VIRUS RESEARCH (2003)
Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges
T Hemachudha et al.
LANCET NEUROLOGY (2002)
Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity
H Badrane et al.
JOURNAL OF VIROLOGY (2001)
Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes
CO Tacket et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
β(1,2)-xylose and α(1,3)-fucose residues have a strong contribution in IgE binding to plant glycoallergens
R van Ree et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure
JM Champion et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2000)
分享论文
